| Nome |
# |
|
Proton pump inhibitors: use and misuse in the clinical setting, file e268c4ca-6722-a6b7-e053-3a05fe0adea1
|
1.907
|
|
Antimicrobial treatment with the fixed-dose antibiotic combination RHB-104 for Mycobacterium avium subspecies paratuberculosis in Crohn’s disease: pharmacological and clinical implications, file e268c4ca-fcf8-a6b7-e053-3a05fe0adea1
|
292
|
|
Improvement in Waldenstrom’s macroglobulinemia after successful treatment of HCV with direct-acting antivirals, file e268c4c9-bf29-a6b7-e053-3a05fe0adea1
|
174
|
|
Relevance of measuring substances in bronchoalveolar lavage fluid for detecting aspiration-associated extraesophageal reflux disease, file e268c4ca-1dbb-a6b7-e053-3a05fe0adea1
|
155
|
|
Low Fibrinogen Levels Are Associated with Bleeding After Varices Ligation in Thrombocytopenic Cirrhotic Patients, file e268c4ca-25ab-a6b7-e053-3a05fe0adea1
|
143
|
|
Vegetal and animal food proteins have a different impact in the first postprandial hour of impedance-pH analysis in patients with heartburn, file e268c4ca-c326-a6b7-e053-3a05fe0adea1
|
107
|
|
Optimal management of constipation associated with irritable bowel syndrome., file e268c4ca-7d60-a6b7-e053-3a05fe0adea1
|
74
|
|
Vonoprazan Fumarate for the Treatment of Gastric Ulcers: A Short Review on Emerging Data, file e268c4cb-ec49-a6b7-e053-3a05fe0adea1
|
71
|
|
Pathophysiological studies are mandatory to understand the benefit of proton pump inhibitors in patients with idiopathic pulmonary fibrosis, file e268c4ca-1dbd-a6b7-e053-3a05fe0adea1
|
65
|
|
Barrett's esophagus in 2016: From pathophysiology to treatment, file e268c4ca-98d9-a6b7-e053-3a05fe0adea1
|
58
|
|
Starry Liver: An Unexpected Diagnosis, file e268c4ca-5b0b-a6b7-e053-3a05fe0adea1
|
56
|
|
Esophageal testing: What we have so far, file e268c4ca-c400-a6b7-e053-3a05fe0adea1
|
53
|
|
Latest insights into the hot question of proton pump inhibitor safety – a narrative review, file e268c4cd-1e82-a6b7-e053-3a05fe0adea1
|
44
|
|
CDKN2A is the main susceptibility gene in Italian pancreatic cancer families., file e268c4c6-0732-a6b7-e053-3a05fe0adea1
|
19
|
|
Peripheral blood cytopaenia limiting initiation of treatment in chronic hepatitis C patients otherwise eligible for antiviral therapy, file e268c4c6-c757-a6b7-e053-3a05fe0adea1
|
8
|
|
Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients., file e268c4c6-b0d6-a6b7-e053-3a05fe0adea1
|
6
|
|
Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease., file e268c4c6-b0d9-a6b7-e053-3a05fe0adea1
|
6
|
|
Breath tests to assess alcoholic liver disease., file e268c4ca-19dc-a6b7-e053-3a05fe0adea1
|
6
|
|
Analyses of the Post-reflux Swallow-induced Peristaltic Wave Index and Nocturnal Baseline Impedance Parameters Increase the Diagnostic Yield of Patients With Reflux Disease, file e268c4ca-9d7f-a6b7-e053-3a05fe0adea1
|
6
|
|
Impairment of chemical clearance and mucosal integrity distinguishes hypersensitive esophagus from functional heartburn, file e268c4ca-3489-a6b7-e053-3a05fe0adea1
|
5
|
|
The added diagnostic value of postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance in refractory reflux disease studied with on-therapy impedance-pH monitoring, file e268c4ca-5041-a6b7-e053-3a05fe0adea1
|
5
|
|
Functional Heartburn Overlaps With Irritable Bowel Syndrome More Often than GERD., file e268c4ca-e9e3-a6b7-e053-3a05fe0adea1
|
5
|
|
Esophageal baseline impedance levels allow the identification of esophageal involvement in patients with systemic sclerosis, file e268c4c8-5211-a6b7-e053-3a05fe0adea1
|
4
|
|
Esophagogastric junction morphology assessment by high resolution manometry in obese patients candidate to bariatric surgery, file e268c4ca-81e2-a6b7-e053-3a05fe0adea1
|
4
|
|
Esophagogastric junction contractility for clinical assessment in patients with GERD: a real added value?, file e268c4ca-bf71-a6b7-e053-3a05fe0adea1
|
4
|
|
Vonoprazan for treatment of gastroesophageal reflux: pharmacodynamic and pharmacokinetic considerations, file e268c4ca-c403-a6b7-e053-3a05fe0adea1
|
4
|
|
A safety review of proton pump inhibitors to treat acid-related digestive diseases, file e268c4ca-c42b-a6b7-e053-3a05fe0adea1
|
4
|
|
Appropriateness of proton pump inhibitors treatment in clinical practice: Prospective evaluation in outpatients and perspective assessment of drug optimisation, file e268c4cc-848a-a6b7-e053-3a05fe0adea1
|
4
|
|
Pharmacological management of gastro-esophageal reflux disease: An update of the state-of-the-art, file e268c4ce-6603-a6b7-e053-3a05fe0adea1
|
4
|
|
Evidence of prolonged orocecal transit time and small intestinal bacterial overgrowth in acromegalic patients, file e268c4c6-0364-a6b7-e053-3a05fe0adea1
|
3
|
|
Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study., file e268c4c6-b35b-a6b7-e053-3a05fe0adea1
|
3
|
|
Interstitial lung disease in systemic sclerosis patients may benefit more from anti-reflux therapies than from immunosuppressants., file e268c4ca-27ca-a6b7-e053-3a05fe0adea1
|
3
|
|
Measurement of oro-caecal transit time by magnetic resonance imaging., file e268c4ca-2824-a6b7-e053-3a05fe0adea1
|
3
|
|
Letter: faecal volatile organic metabolites, promising biomarkers in inflammatory bowel disease., file e268c4ca-31af-a6b7-e053-3a05fe0adea1
|
3
|
|
A review of pharmacotherapy for treating gastroesophageal reflux disease (GERD), file e268c4ca-6732-a6b7-e053-3a05fe0adea1
|
3
|
|
Association Between Baseline Impedance Values and Response Proton Pump Inhibitors in Patients With Heartburn, file e268c4ca-694a-a6b7-e053-3a05fe0adea1
|
3
|
|
Fecal calprotectin in systemic sclerosis: Light and shade of a promising tool., file e268c4ca-7129-a6b7-e053-3a05fe0adea1
|
3
|
|
Improvement in hepatitis C virus patients with advanced, compensated liver disease after sustained virological response to direct acting antivirals, file e268c4ca-77c7-a6b7-e053-3a05fe0adea1
|
3
|
|
Letter: it is time to adopt new objective parameters to accurately identify patients with functional heartburn, file e268c4ca-7937-a6b7-e053-3a05fe0adea1
|
3
|
|
Comparison of Two Different Techniques to Assess Adalimumab Trough Levels in Patients with Crohn's Disease., file e268c4ca-7ce2-a6b7-e053-3a05fe0adea1
|
3
|
|
Lactulose breath test to assess oro-cecal transit delay and estimate esophageal dysmotility in scleroderma patients., file e268c4ca-801f-a6b7-e053-3a05fe0adea1
|
3
|
|
Letter: Treatment for small intestinal bacterial overgrowth - Where are we now?, file e268c4ca-8162-a6b7-e053-3a05fe0adea1
|
3
|
|
High-resolution manometry is superior to endoscopy and radiology in assessing and grading sliding hiatal hernia: A comparison with surgical in vivo evaluation, file e268c4ca-ebb0-a6b7-e053-3a05fe0adea1
|
3
|
|
Prevalence of Lactose Intolerance in Patients with Hashimoto Thyroiditis and Impact on LT4 Replacement Dose, file 47bf2204-cd0a-40b6-8f31-950c92ff5486
|
2
|
|
Colorectal Cancer in Inflammatory Bowel Diseases: Epidemiology and Prevention: A Review, file 7ae9f4ca-2f3c-4078-8de4-a69fab74705d
|
2
|
|
Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy., file e268c4c6-ceca-a6b7-e053-3a05fe0adea1
|
2
|
|
Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough, file e268c4ca-241a-a6b7-e053-3a05fe0adea1
|
2
|
|
Gastrointestinal motility disorder assessment in systemic sclerosis., file e268c4ca-2712-a6b7-e053-3a05fe0adea1
|
2
|
|
Not all anti-reflux treatment failures are due to persistence of abnormal esophageal acid exposure, file e268c4ca-403d-a6b7-e053-3a05fe0adea1
|
2
|
|
A Comparison Between Lactose Breath Test and Quick Test on Duodenal Biopsies for Diagnosing Lactase Deficiency in Patients With Self-reported Lactose Intolerance., file e268c4ca-4220-a6b7-e053-3a05fe0adea1
|
2
|
|
A Nodule, is a Nodule, is a Nodule: May Alpha-fetoprotein Make the Difference?, file e268c4ca-4c4d-a6b7-e053-3a05fe0adea1
|
2
|
|
The appropriate use of proton-pump inhibitors, file e268c4ca-6728-a6b7-e053-3a05fe0adea1
|
2
|
|
Infliximab trough levels and persistent vs transient antibodies measured early after induction predict long-term clinical remission in patients with inflammatory bowel disease, file e268c4ca-7ead-a6b7-e053-3a05fe0adea1
|
2
|
|
Overweight is a risk factor for both erosive and non-erosive reflux disease., file e268c4ca-8017-a6b7-e053-3a05fe0adea1
|
2
|
|
Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth., file e268c4ca-bfcf-a6b7-e053-3a05fe0adea1
|
2
|
|
Pathophysiology, diagnosis, and pharmacological treatment of gastro-esophageal reflux disease, file e268c4cc-3683-a6b7-e053-3a05fe0adea1
|
2
|
|
Voluntary and controlled weight loss can reduce symptoms and proton pump inhibitor use and dosage in patients with gastroesophageal reflux disease: A comparative study, file e268c4cc-8f2d-a6b7-e053-3a05fe0adea1
|
2
|
|
A SIGE-SINGEM-AIGO technical review on the clinical use of esophageal reflux monitoring, file e268c4cd-04ba-a6b7-e053-3a05fe0adea1
|
2
|
|
Dietary Management of Eosinophilic Esophagitis: Tailoring the Approach, file e268c4ce-0750-a6b7-e053-3a05fe0adea1
|
2
|
|
Prevention Strategies for Esophageal Cancer—An Expert Review, file e268c4ce-0d07-a6b7-e053-3a05fe0adea1
|
2
|
|
Intragastric acidity and serum gastrin after sufotidine (I), file 1654ee06-0c5b-4326-8bf4-1ee229fba432
|
1
|
|
Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis, file e268c4c5-ea67-a6b7-e053-3a05fe0adea1
|
1
|
|
Combined multichannel intraluminal impedance and pH-metry: a novel technique to improve detection of gastro-oesophageal reflux literature review., file e268c4c6-10ae-a6b7-e053-3a05fe0adea1
|
1
|
|
NERD: an umbrella term including heterogeneous subpopulations., file e268c4c6-ba41-a6b7-e053-3a05fe0adea1
|
1
|
|
Reduction of hexavalent chromium by fasted and fed human gastric fluid. I. Chemical reduction and mitigation of mutagenicity, file e268c4c7-aa6e-a6b7-e053-3a05fe0adea1
|
1
|
|
Reduction in TIMP-2 serum levels predicts remission of inflammatory bowel diseases, file e268c4c9-a8ef-a6b7-e053-3a05fe0adea1
|
1
|
|
Prognostic role of mean platelet volume in patients with cirrhosis, file e268c4ca-19d4-a6b7-e053-3a05fe0adea1
|
1
|
|
Epidemiology and natural history of gastroesophageal reflux disease, file e268c4ca-1f85-a6b7-e053-3a05fe0adea1
|
1
|
|
Esophagogastric junction morphology is associated with a positive impedance-pH monitoring in patients with GERD, file e268c4ca-1f8c-a6b7-e053-3a05fe0adea1
|
1
|
|
It is Time to Re-Think the Role of Small Intestinal Bacterial Overgrowth in IBS Patients., file e268c4ca-241e-a6b7-e053-3a05fe0adea1
|
1
|
|
Manually calculated oesophageal bolus clearance time increases in parallel with reflux severity at impedance-pH monitoring, file e268c4ca-275c-a6b7-e053-3a05fe0adea1
|
1
|
|
Measurement of sorafenib plasma concentration by high-performance liquid chromatography in patients with advanced hepatocellular carcinoma: is it useful the application in clinical practice? A pilot study, file e268c4ca-38e8-a6b7-e053-3a05fe0adea1
|
1
|
|
Hepatobiliary and Pancreatic: A rare cause of portal hypertension., file e268c4ca-4024-a6b7-e053-3a05fe0adea1
|
1
|
|
Positive PET in a patient with esophageal leiomyoma., file e268c4ca-41fc-a6b7-e053-3a05fe0adea1
|
1
|
|
Anti-TNF therapy is able to stabilize bowel damage progression in patients with Crohn's disease. A study performed using the Lémann Index, file e268c4ca-433d-a6b7-e053-3a05fe0adea1
|
1
|
|
An independent validation of the mortality score for the short-term prognostic prediction in patients with chronic hepatitis C virus infection and advanced liver disease, file e268c4ca-5482-a6b7-e053-3a05fe0adea1
|
1
|
|
Non-invasive Assessment of Varices Needing Treatment in Patients with Cirrhosis: No One Should Be Left Behind, file e268c4ca-5564-a6b7-e053-3a05fe0adea1
|
1
|
|
Adalimumab trough serum levels and anti-adalimumab antibodies in the long-term clinical outcome of patients with Crohn’s disease., file e268c4ca-5db6-a6b7-e053-3a05fe0adea1
|
1
|
|
Prevalence and clinical characteristics of refractoriness to optimal proton pump inhibitor therapy in non-erosive reflux disease, file e268c4ca-6726-a6b7-e053-3a05fe0adea1
|
1
|
|
Vigor of peristalsis during multiple rapid swallows is inversely correlated with acid exposure time in patients with NERD, file e268c4ca-768e-a6b7-e053-3a05fe0adea1
|
1
|
|
Adalimumab trough levels and response to biological treatment in patients with Inflammatory Bowel Disease: a useful cut-off In clinical practice., file e268c4ca-7f24-a6b7-e053-3a05fe0adea1
|
1
|
|
Effects of bariatric surgery on the esophagus, file e268c4ca-9fc1-a6b7-e053-3a05fe0adea1
|
1
|
|
A randomized, 6-wk trial of a low FODMAP diet in patients with inflammatory bowel disease, file e268c4ca-a82f-a6b7-e053-3a05fe0adea1
|
1
|
|
Are proton pump inhibitors really so dangerous?, file e268c4ca-b065-a6b7-e053-3a05fe0adea1
|
1
|
|
Ilaprazole for the treatment of gastro-esophageal reflux, file e268c4ca-b067-a6b7-e053-3a05fe0adea1
|
1
|
|
Lower pH values of weakly acidic refluxes as determinants of heartburn perception in gastroesophageal reflux disease patients with normal esophageal acid exposure, file e268c4ca-b06b-a6b7-e053-3a05fe0adea1
|
1
|
|
The prevention of NSAID-induced gastric ulcers is a firmly established PPI indication, file e268c4ca-c137-a6b7-e053-3a05fe0adea1
|
1
|
|
Tryciclic Antidepressants in Refractory GERD: Poorly Effective Drugs or Wrong Patients?, file e268c4ca-c319-a6b7-e053-3a05fe0adea1
|
1
|
|
Letter: Biologics are effective in neutralising the detrimental effect of smoking on the natural course of Crohn's disease, file e268c4ca-c31d-a6b7-e053-3a05fe0adea1
|
1
|
|
The natural history of gastro-esophageal reflux disease: A comprehensive review, file e268c4ca-c320-a6b7-e053-3a05fe0adea1
|
1
|
|
Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non-erosive reflux disease – efficacy of Esoxx, a hyaluronic acid–chondroitin sulphate based bioadhesive formulation, file e268c4ca-ddb4-a6b7-e053-3a05fe0adea1
|
1
|
|
The GerdQ questionnaire and high resolution manometry support the hypothesis that proton pump inhibitor-responsive oesophageal eosinophilia is a GERD-related phenomenon, file e268c4ca-ddba-a6b7-e053-3a05fe0adea1
|
1
|
|
Letter: proton pump inhibitor-responsive oesophageal eosinophilia – more than just gastro-oesophageal reflux disease. Authors' reply, file e268c4ca-ee95-a6b7-e053-3a05fe0adea1
|
1
|
|
Impedance-detected symptom association and number of reflux episodes as pre-treatment parameters that predict outcomes of gastroesophageal reflux disease patients, file e268c4ca-f5b8-a6b7-e053-3a05fe0adea1
|
1
|
|
Anti-TNF Antibodies For Prevention of Crohn's Disease Recurrence After Surgery: More Than An Hope., file e268c4ca-fa68-a6b7-e053-3a05fe0adea1
|
1
|
|
High anti-TNF alfa drugs trough levels are not associated with the occurrence of adverse events in patients with inflammatory bowel disease, file e268c4cb-5489-a6b7-e053-3a05fe0adea1
|
1
|
|
Psoriasis and small intestine bacterial overgrowth, file e268c4cc-bbce-a6b7-e053-3a05fe0adea1
|
1
|
| Totale |
3.406 |